Hey there! Welcome!
Get updated on
Select Speciality
Top Picks
18 Nov, 26
HF & CKD are interlinked; ESC 2026 CVD-CKD Guidelines focus on the need of integrated management of CVD-CKD. Routine eGFR/UACR screening, GDMT & proactive hyperkalemia management may improve survival, cut hospitalizations, & preserve renal function.
13 Nov, 26
AHA 2026
The sessions presented at AHA 2026, underscore the importance of secondary prevention in MI patients and focus on the benefits of beta-blocker treatment and reperfusion treatment in these patients.
17 Nov, 26
Eur J Prev Cardiol.
- Elevated remnant cholesterol [≥1 mmol/L (39 mg/dL)] was more prevalent in familial hypercholesterolemia (FH) population (12%-78%) vs non-FH individuals (11%-12%)
- Across CGPS & UK Biobank, remnant cholesterol ≥1 mmol/L was associated with higher CAD risk in FH (HRs 1.14-1.60) & non-FH subjects (HR 1.47-1.49), conferring an approximately 50% additional CAD risk beyond lifelong LDL-C elevation in FH individuals.
17 Nov, 26
A 35-year-old woman with ESRD on maintenance hemodialysis experienced recurrent decompensated HFrEF (LVEF 28%), with severe MR and TR, and pulmonary hypertension despite medical therapy. Click here to read the treatment.
17 Nov, 26
A 20-month-old girl developed blistering after amoxicillin therapy, with characteristic “string-of-pearls” lesions. Persistent blistering despite initial treatment required escalation for refractory linear IgA bullous dermatosis. Click here to read the treatment.
16 Nov, 26
BMC Pedia
- Using hemoglobin and serum ferritin , normal iron status was observed in 82-90% of infants during the first year.
- Iron deficiency prevalence increased from 5.6-11.5% (Hb+SF) to 20.2-27.7% when zinc protoporphyrin (ZnPP) was included.
- Anemia affected 4.5-7.7% of infants; >50% of cases were non-iron deficiency anemia (non-IDA), and biomarker agreement was low.
Featured

12 Nov, 26

26 Oct, 26

26 Oct, 26






















